Skip to content

    Kiri Industries Limited

    KIRIINDUSMixed
    Chemicals·7 Nov 2025
    Management Summary

    Kiri Industries reported mixed Q2 FY26 results, with strong revenue growth on both standalone and consolidated bases, but profitability was significantly impacted by elevated legal expenses related to the ongoing DyStar litigation and higher finance costs. The DyStar transaction faced further delays, extending the long-stop date to December 1, 2025, though a second bidder has been engaged. The company continues to advance its strategic copper project, with clear timelines for trial production and substantial progress in fund utilization.

    Highlights

    8
    • Standalone Q2 FY26 revenue grew 34% YoY to ₹195 crores, and 8% sequentially.

    • Standalone Q2 FY26 reported an EBITDA loss of ₹10 crores and a net loss of ₹21 crores, primarily due to elevated legal expenses.

    • Consolidated Q2 FY26 revenue increased 23% YoY to ₹213 crores, and 6% sequentially.

    • Consolidated Q2 FY26 reported an EBITDA loss of ₹13 crores and a net loss of ₹80 crores (before share of profit from associates/OCI), impacted by ₹61 crores in finance costs.

    • For H1 FY26, consolidated revenue was ₹416 crores (up 17% YoY), with a net loss of ₹131 crores (before share of profit from associates).

    • The DyStar transaction long-stop date has been extended to December 1, 2025, with an additional US$5.11 million deposited into escrow.

    • A second bidder for DyStar has been inducted into the process, with management expressing >90% confidence in transaction completion by December 31, 2025, if the second bidder is chosen.

    • The copper project is targeting trial productions between January 2026 and December 2028, with 70% of borrowed funds already utilized.

    Concerns

    1
    • DyStar Transaction Delays due to Chinese Regulatory Approvals

    What Changed3

    vs Q3 FY26

    Guidance items11 → 6 (-5)Risks discussed3 → 4 (+1)Q&A highlights8 → 3 (-5)

    Key financials

    Single quarter

    10 metrics
    1. 01Standalone Revenue₹195 Cr+34%YoY
    2. 02Standalone EBITDA Loss₹10 Cr
    3. 03Standalone Net Loss₹21 Cr
    4. 04Consolidated Revenue₹213 Cr+23%YoY
    5. 05Consolidated EBITDA Loss₹13 Cr

    Guidance & targets

    6
    CategoryTargetPriority
    Other
    DyStar Transaction Completion
    by December 31, 2025
    Medium
    Other
    DyStar Transaction Completion (Second Bidder)
    more than 90%
    High
    Capacity
    Copper Project Trial Production
    January 2026 to December 2028
    High
    Capex
    Copper Project Borrowed Funds Utilization
    100%
    High
    Debt
    Copper Project Interest Rate
    8.5% to 9%
    High
    Dividend
    Dividend Payout
    Yes
    High

    Risks & concerns

    4
    RiskSeverity

    DyStar Transaction Delays due to Chinese Regulatory Approvals

    Longsheng's repeated inability to obtain NDRC and Ministry of Commerce approvals has led to multiple extensions, causing prolonged uncertainty for the DyStar sale.Management acknowledged

    high

    Elevated Legal Expenses

    Ongoing legal costs related to the DyStar case continue to impact profitability, though management expects a drastic drop post-transaction completion.Management acknowledged

    medium

    Raw Material Volatility

    Intermittent volatility in naphthalene-based feedstocks and other petrochemical derivatives affects the intermediates segment's profitability.Management acknowledged

    medium

    Mistrust and Opacity in Chinese Regulatory Process

    Management expresses '50-50' mistrust regarding whether Longsheng's delays are genuine or engineered, highlighting the opacity of the Chinese regulatory environment.Management acknowledged

    medium

    Q&A highlights

    3

    “So on November 3rd when the extension was given, the reason which was explained to us was not being able to obtain NDRC approval and Ministry of Commerce approval which Longsheng was supposed to obtain to conclude the transaction. ... So in case if the approvals are not obtained by December 1st, we are going to continue to strongly recommend the receiver to discard and terminate Longsheng from the process and terminate SPA which the receiver can very well do now.”

    Clarifies the specific regulatory hurdles causing delays and management's proactive stance on pushing for termination and court intervention if the new deadline is missed.

    asked by Khem

    3 min read7 chapters

    Detailed Narrative

    01

    Q2 & H1 FY26 Financial Performance Overview

    Kiri Industries reported a standalone revenue of ₹195 crores for Q2 FY26, marking a significant 34% year-on-year growth and an 8% sequential increase. Despite this revenue growth, the company recorded a standalone EBITDA loss of ₹10 crores and a net loss of ₹21 crores, primarily attributed to elevated legal expenses from the DyStar case and higher operating costs. For the first half of FY26, standalone revenue reached ₹375 crores, growing 20% YoY, with an EBITDA of ₹7 crores and a net loss of ₹14 crores.

    02

    Consolidated Results and Profitability Challenges

    On a consolidated basis, Kiri Industries achieved ₹213 crores in revenue for Q2 FY26, representing a 23% YoY and 6% sequential growth. However, consolidated performance was impacted by an EBITDA loss of ₹13 crores and a net loss of ₹80 crores before considering the share of profit from associates and other OCI. High finance costs of ₹61 crores and elevated input costs were key contributors to the consolidated losses. For H1 FY26, consolidated revenue was ₹416 crores (up 17% YoY), with a net loss of ₹131 crores before the share of profit from associates, which stood at ₹161 crores.

    03

    DyStar Transaction Update and Persistent Delays

    The sale of Kiri's 37.57% stake in DyStar, valued at $1.9 billion (with Kiri's potential consideration around $696 million), continues to face delays. The long-stop date, initially October 2, 2025, and then November 3, 2025, has been further extended to December 1, 2025. This extension was granted because the purchaser, Longsheng, could not obtain necessary regulatory approvals from NDRC and the Ministry of Commerce in China. An additional US$5.11 million has been deposited into the escrow account, bringing the total to US$8.59 million.

    04

    Engagement of Second Bidder and Outlook for Completion

    In response to the ongoing delays, a financially strong second bidder has been inducted into the DyStar sale process. This bidder has provided proof of funds, and confirmatory due diligence and draft sale-purchase agreement exchanges are already underway. Management expressed confidence that the transaction could still be concluded by December 31, 2025, especially if the second bidder is chosen, with a 'more than 90%' probability of completion by that date. Kiri Industries is actively urging the receiver to terminate Longsheng if they fail to meet the December 1st deadline.

    05

    Strategic Diversification: Indo-Asia Copper Project Progress

    Kiri Industries is advancing its strategic diversification into the copper and fertilizer sectors through its step-down subsidiary, Indo-Asia Copper Limited (IACL). The integrated complex at Jafrabad, Gujarat, will feature a 5 lakh tonnes per annum copper smelter and a fertilizer plant utilizing sulfuric acid. Basic engineering for the project is complete, and 60% of detailed engineering is targeted for completion by February 2026. Trial productions for the copper plant are projected to commence between January 2026 and December 2028.

    06

    Copper Project Financing and Legal Cost Management

    Approximately 70% of the borrowed funds for the copper project have already been utilized for land acquisition, vendor payments, and machinery orders, with 100% utilization expected within the next 'two, three months.' The project's financing involves a mix of dollar and rupee, with an estimated interest rate of 8.5% to 9%. Legal costs, currently elevated due to the ongoing DyStar litigation, are expected to 'drastically drop' once the sale proceeds from the DyStar transaction are received in the company's account.

    07

    Operational Performance in Dyes and Intermediates

    The dyes and intermediates industry experienced a gradual recovery in Q2 FY26, supported by improved downstream textile demand and normalized global freight conditions. Reactive dyes maintained positive momentum with firm export enquiries. However, intermediates such as vinyl sulphone and H. Acid were affected by intermittent raw material volatility, particularly in naphthalene-based feedstocks. The company continues to focus on operational discipline, cost optimization, and rationalizing its product mix to enhance export competitiveness and mitigate external volatility🌐.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.